Response to Martani, Tomasi, and Casanto-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Martani, Tomasi, and Casanto

Published:2020-11-30 Issue:3 Volume:113 Page:340-341
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Master Zubin¹^ORCID,Adjei Alex A²,Hargraves Ian G³^ORCID,Montori Victor M³^ORCID,Tilburt Jon C⁴

Affiliation:

1. Biomedical Ethics Research Program and Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA

2. Department of Oncology, Mayo Clinic, Rochester, MN, USA

3. Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA

4. Biomedical Ethics Research Program and General Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djaa192/34597449/djaa192.pdf

Reference6 articles.

1. Re: “I think it’s been met with a shrug:” Oncologists’ views toward and experiences with Right-to-Try;Martani;J Natl Cancer Inst,2020

2. “I think it’s been met with a shrug:” Oncologists’ views toward and experiences with Right-to-Try;Smith;J Natl Cancer Inst,2020

3. Ethical concerns regarding private equity in right to try in the USA;Lee;Lancet Oncol,2020

4. End-of-life conversations: evolving practice and theory;Larson;JAMA,2000

5. Purposeful SDM: a problem-based approach to caring for patients with shared decision-making;Hargraves;Patient Educ Couns,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try;Journal of Law and the Biosciences;2022-07-01

2. Oncologists’ reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center;PLOS ONE;2021-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3